WallStSmart
INM

InMed Pharmaceuticals Inc

NASDAQ: INM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$0.70
+0.00% today

Updated 2026-04-29

Market cap
$2.43M
P/E ratio
P/S ratio
0.54x
EPS (TTM)
$-2.88
Dividend yield
52W range
$1 – $6
Volume
0.1M

InMed Pharmaceuticals Inc (INM) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-577403.00$-1.40M$-951153.00$100479.00$-195417.00$-562055.00$-174618.00$-39262.00$-641381.00$-1.61M$-386071.00$-2.37M$-3.68M$-6.68M$-7.37M$-9.79M$-15.58M$-7.28M$-6.99M$-7.77M
Capital expenditures$0.00$12524.00$24851.00$0.00$0.00$0.00$0.00$0.00$2034.00$4844.00$885.00$19524.00$43803.00$27034.00$42573.00$1725.00$39108.00$161804.00$9293.00$0.00
Depreciation
Stock-based comp$95807.00$666831.00$1.69M$695202.00$1.17M$2.43M$3.11M$994401.00$610193.00$697894.00$278155.00$137714.00$119307.00
Free cash flow$-577403.00$-1.41M$-976004.00$100479.00$-195417.00$-562055.00$-174618.00$-39262.00$-643415.00$-1.61M$-386956.00$-2.38M$-3.72M$-6.71M$-7.42M$-9.79M$-15.62M$-7.45M$-7.00M$-7.77M
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash